Venky's (India) Limited VENKEYS NSE
Venky's (India) Limited primarily engages in the production and sale of poultry products in India and internationally. It operates through three segments: Poultry and Poultry Products, Animal Health Products, and Oilseed. The Poultry and Poultry Products segment produces and sells day old broiler and layer chicks, pathogen free eggs, processed chicken products, grownup commercial broiler, poultry feed, and other miscellaneous poultry products. Its Animal Health Products segment produces and sells medicines and other health products for birds. The Oilseed segment produces and sells edible refined soya oil and soya de-oiled cake. It also provides nutritional supplements, toxin binders, liver tonics, acidifiers, health promoters, iron tonic, antibiotics, anti-mycoplasma, dewormers, anti-gout, and electrolytes; disinfectants, water sanitizers, cleaners, and equipment; vitamin premixes and prebiotics; sports and medical nutrition, therapy products; egg powders; vaccines; and feed supplements. In addition, it provides PDRC; IMPT; and import and export services. The company was formerly known as Western Hatcheries Limited. Venky's (India) Limited was incorporated in 1976 and is based in Pune, India. Venky's (India) Limited is a subsidiary of Venkateshwara Hatcheries Private Limited.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Profit CAGR of 25.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -2.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | VENKEYS Venky's (India) Limited NSE | 1,454.00 | 14.71 | ₹2,048.30 Cr | 0.69% | 12.13% | 9.07% | -2.78% | 25.48% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,153.50 | 47.62 | ₹5.06 L Cr | 2.04% | 22.15% | 21.60% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 286.90 | 17.39 | ₹3.59 L Cr | 5.58% | 36.47% | 29.34% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,421.50 | 78.10 | ₹2.74 L Cr | 0.84% | 59.30% | 76.34% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 4,054.50 | 88.49 | ₹2.64 L Cr | - | 16.41% | 12.94% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 528.00 | 56.17 | ₹1.79 L Cr | 0.38% | 19.44% | - | 17.26% | 26.57% |
| 7 | TATACONSUM Tata Consumer Products Limited NIFTY50NSE | 1,178.40 | 75.78 | ₹1.17 L Cr | 0.85% | 8.29% | 6.94% | 13.87% | 8.61% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 821.70 | 60.60 | ₹1.06 L Cr | 0.49% | 39.00% | 41.39% | 12.00% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,029.30 | 56.49 | ₹1.05 L Cr | 1.94% | 21.44% | 15.10% | 4.59% | 3.02% |
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 843.16 Cr | 865.83 Cr | 800.87 Cr | 960.15 Cr | 1,100.47 Cr |
| Cost of Revenue | 644.23 Cr | 668.43 Cr | 650.19 Cr | 698.99 Cr | 780.89 Cr |
| Gross Profit | 198.93 Cr | 197.40 Cr | 150.68 Cr | 261.16 Cr | 319.58 Cr |
| Operating Expenses | 183.54 Cr | 183.03 Cr | 191.08 Cr | 200.54 Cr | 199.19 Cr |
| Operating Income | 15.39 Cr | 14.37 Cr | -40.40 Cr | 60.62 Cr | 120.39 Cr |
| EBITDA | 37.25 Cr | 35.27 Cr | -20.78 Cr | 79.71 Cr | 145.49 Cr |
| Interest Expense | 4.28 Cr | 4.29 Cr | 5.04 Cr | 4.31 Cr | 3.40 Cr |
| Pretax Income | 22.99 Cr | 21.77 Cr | -35.08 Cr | 66.14 Cr | 132.72 Cr |
| Tax Provision | 9.69 Cr | 5.94 Cr | -8.55 Cr | 17.56 Cr | 31.35 Cr |
| Net Income | 13.30 Cr | 15.83 Cr | -26.53 Cr | 48.58 Cr | 101.37 Cr |
| Diluted EPS | 9.44 | 11.24 | -18.83 | 34.48 | 71.96 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 4,056.51 Cr | 3,609.86 Cr | 3,306.99 Cr | 3,727.32 Cr |
| Cost of Revenue | - | 3,591.87 Cr | 3,059.07 Cr | 2,443.40 Cr | 2,798.50 Cr |
| Gross Profit | - | 464.64 Cr | 550.79 Cr | 863.59 Cr | 928.82 Cr |
| Operating Expenses | - | 377.65 Cr | 453.52 Cr | 728.72 Cr | 773.84 Cr |
| Operating Income | - | 86.99 Cr | 97.27 Cr | 134.87 Cr | 154.98 Cr |
| EBITDA | - | 149.24 Cr | 162.61 Cr | 215.78 Cr | 239.69 Cr |
| Interest Expense | - | 18.48 Cr | 18.18 Cr | 16.34 Cr | 17.04 Cr |
| Pretax Income | - | 95.30 Cr | 109.42 Cr | 162.71 Cr | 185.55 Cr |
| Tax Provision | - | 24.81 Cr | 30.36 Cr | 46.09 Cr | 46.30 Cr |
| Net Income | - | 70.48 Cr | 79.07 Cr | 116.62 Cr | 139.25 Cr |
| Diluted EPS | - | 50.03 | 56.13 | 82.78 | 98.85 |
Compounded Sales Growth
| 5 Years: | -2.78% |
| 1 Year: | 30.50% |
Compounded Profit Growth
| 5 Years: | 25.48% |
| 1 Year: | 662.60% |
Stock Price Performance
| 1 Year: | -9.70% |
| 6 Months: | +8.59% |
| 3 Months: | +6.37% |
| 1 Month: | -8.12% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 2,014.88 Cr | 2,093.75 Cr | 2,070.34 Cr | 2,308.66 Cr |
| Current Assets | - | 1,342.14 Cr | 1,313.40 Cr | 1,342.52 Cr | 1,418.29 Cr |
| Cash & Equivalents | - | 18.51 Cr | 17.10 Cr | 14.88 Cr | 62.16 Cr |
| Inventory | - | 387.11 Cr | 373.11 Cr | 458.99 Cr | 552.32 Cr |
| Receivables | - | 656.31 Cr | 715.04 Cr | 553.81 Cr | 544.04 Cr |
| Total Liabilities | - | 716.27 Cr | 723.51 Cr | 594.77 Cr | 712.57 Cr |
| Current Liabilities | - | 664.59 Cr | 665.91 Cr | 530.54 Cr | 638.60 Cr |
| Long Term Debt | 4.75 Cr | 0 | 0 | - | 9.50 Cr |
| Total Debt | - | 190.63 Cr | 172.00 Cr | 169.66 Cr | 166.51 Cr |
| Total Equity | - | 1,298.61 Cr | 1,370.24 Cr | 1,475.57 Cr | 1,596.09 Cr |
| Shares Outstanding | - | 1.41 Cr | 1.41 Cr | 1.41 Cr | 1.41 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 86.11 Cr | 81.97 Cr | 66.20 Cr | 191.32 Cr |
| Investing Cash Flow | - | -26.55 Cr | -36.62 Cr | -38.27 Cr | -108.37 Cr |
| Financing Cash Flow | - | -45.03 Cr | -46.87 Cr | -30.14 Cr | -35.67 Cr |
| Capital Expenditure | - | -42.28 Cr | -50.36 Cr | -45.83 Cr | -41.13 Cr |
| Free Cash Flow | - | 43.83 Cr | 31.61 Cr | 20.37 Cr | 150.19 Cr |
| Net Change in Cash | - | 14.53 Cr | -1.52 Cr | -2.21 Cr | 47.28 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 11.5% | 15.3% | 26.1% | 24.9% |
| Operating Margin % | - | 2.1% | 2.7% | 4.1% | 4.2% |
| Net Margin % | - | 1.7% | 2.2% | 3.5% | 3.7% |
| ROE % | - | 5.4% | 5.8% | 7.9% | 8.7% |
| ROCE % | - | 6.4% | 6.8% | 8.8% | 9.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VENKEYS